Své výsledky v oblasti vědy a výzkumu Ústav patologické fyziologie aktivně prezentoval v období 2021 – 2024 na těchto mezinárodních kongresech:
ASHI 2024 - The American Society for Histocompatibility and Immunogenetics 50th Annual Meeting, October 21-25, 2024, Anaheim, California, United States Petrek M, Sikorova K, Kocourkova L, Dobias M, Petrkova J. HLA-DPB1*23:01 is associated with severe cardiac conditions, sudden cardiac death and ventricular fibrillation, in Czech patients. Hum Immunol. 2024;85(Suppl.):112.
ERS 2024 – European Respiratory Society (ERS) International Congress, September 7-11, 2024, Vienna, Austria Komínková E, Navrátilová Z, Petřek M. The mRNA expression of the TGF-beta signalling pathway in Pulmonary Sarcoidosis. Eur Respir J. 2024;64(suppl. 68): PA2477. (poster)
Petřek M, Rapti A, Song JW, Doubkova M, Strnad A, Petrkova J, Sikorova K, Bouros D. HLA genes and sarcoidosis across three populations: Greeks, Czechs, and Koreans. Eur Respir J. 2024;64(suppl. 68):PA2489. (poster)
Rivera NV, Chuquimia OD, Pezant N, Kerick M, Meguro A, Van Moorsel C, Manali ED, Petrek M, Bastos HN, Carvalho A, Azuma A, Ishihara M, Takeuchi M, Mizuki N, Van Der Vis A, Wind A, Gazouli M, Gialafos E, Spyropoulos G, Domvri K, Papakosta D, Darlington P, Grunewald J, Kolek V, Navratilova Z, Jakubec P, Sikorova K, Doubkova M, Cunha C, Santos R, Morais A, Papiris SA, Veltkamp M, Grutters J, Martin J, Mañá J, Iriarte A, Montgomery C, Kullberg S, Padyukov L, Mesargen Consortium. Deciphering the genetic tapestry: Insights into sarcoidosis across diverse populations with the MESARGEN Consortium. Eur Respir J. 2024;64(suppl 68):OA952. (ústní sdělení)
ESC 2024 – European Society of Cardiology Congress, August 30 – September 2, 2024, London. United Kingdom Petrkova J, Gavronova A, Sarvasova K, Bobek M, Dobias M, Petrek M. Coronary heart disease: leading cause of cardiovascular death from analysis of autopsies in a central european university centre. Eur Heart J. 2024;45(Suppl_1):ehae666.1344. (komentovaný poster)
EAS 2024 – European Atherosclerosis Society Congress, May 26-29, 2024, Lyon, France Petrkova J, Kocourkova L, Obrova J, Taborsky M, Petrek M. Evaluation of the pathogenic variants in the ApoB, LDLR, and ApoE genes in the Czech subjects: preliminary report. Atherosclerosis 2024;395(S1):118. (poster)
EFI 2024 – 37th European Immunogenetics and Histocompatibility Conference, May 20-23, 2024, Geneva, Switzerland Gerbault P, Heijmans C, Goeury T, Faye NK, Di D, Augusto DG, Petzl-Erler ML, Petrek M, Singh M, Nunes JM, de Groot N, Sanchez-Mazas A. Evolution trajectories of the Major Histocompatibility Complex (MHC) class I genes in humans, chimpanzees and bonobos. HLA 2024;103(S1):38. (ústní sdělení)
Petrek M, Sikorova K, Kocourkova L, Dobias M, Petrkova J. Sudden Cardiac Death and HLA variation – report from the initial phase of investigations. HLA 2024;103(S1):54. (poster)
ATS 2024 - American Thoracic Society 2024 International Conference, May 17-22, 2024, San Diego, California, USA Volakova E, Petrkova J, Petrek M, Jakubec P. Primary Spontaneous Pneumothorax As A Clinical Manifestation Of Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med. 2024;209:A3796. (poster)
ERS 2023 – European Respiratory Society (ERS) International Congress, September 9-13, 2023, Milan, Italy Volakova E, Petrkova J, Kocourkova L, Zatloukal J, Jakubec P, Petrek M. Gene mutations and clinical manifestations of alpha-1 antitrypsin deficiency in Czech patients – a pilot study. Eur Respir J. 2023;62:(Suppl. 67): PA2719. (komentovaný poster)
EFI 2023 – 36th European Immunogenetics and Histocompatibility Conference, April 26-29, 2023, Nantes, France Sikorová K, Doubková M, Strnad A, Kocourková L, Petřková J, Osoegawa K, Fernández-Viña MA, Petrek M. HLA variants associated with sarcoidosis and their tag single nucleotide polymorphisms in Czechs. HLA 2023;111(4):372-373. (poster)
ERS 2022 – European Respiratory Society (ERS) International Congress, September 4 – 6, 2022, Barcelona, Spain Sikorová K, Yoon H-Y, Strnad A, Kocourková L, Moon S-j, Song JW, Petrek M. Polymorphisms in immune related genes are associated with Sarcoidosis in Korean Population. Eur Respir J. 2022;60(Suppl. 66): 2957. (komentovaný poster)
EFI 2022 – 35th European Immunogenetics and Histocompatibility Conference, May 17 – 20, 2022, Amsterdam, the Netherlands Sikorova K, Gavronova A, Petrkova J, Kocourkova L, Osoegawa K, Fernández-Viña MA, Petrek M. HLA variants and severe COVID-19: preliminary report from Czechia. HLA 2022;99(5):527. (poster)
ATS 2021 Virtual Conference – American Thoracic Society 2021 International Conference, May 14 – 19, 2021 Petrek M, Strnad A, Sikorova K, Rapti A, Bouros D, Charikiopoulou M, Kalianos A. Association of HLA variants with sarcoidosis in Greek population. Am J Respir Crit Care Med. 2021;203:A1324. (komentovaný poster)
The virtual EAS Congress 2021 – European Atherosclerosis Society Congress, May 30 – June 2, 2021 Petrek M, Petrkova J, Kocourkova L. Adoption of Multiplex MassArray Technology for Determination of Dyslipidemia Relevant Gene Variants. Atherosclerosis 2021;331:e218. Meeting Abstract P510. (e-poster)
ERS 2021 – European Respiratory Society (ERS) International Congress, virtual, September 4 – 8, 2021 Sikorová K, Žižková V, Kocourková L, Strnad A, Doubková M, Petřek M. HLA associations in Czech Patients with Sarcoidosis. (komentovaný poster)
ISA 2021 – The 19th International Symposium on Atherosclerosis, Hybrid Format (onsite and online), Kyoto, Japan, October 24 – 27, 2021 Petrek M, Petrkova J, Kociánová E, Kocourková L, Táborský M. Detection of monogenic familial hypercholesterolaemia using a novel genotyping technique – report from implementation and pilot testing phase. Abstracts Book, page 318. (vybráno k prezentaci jako ústní sdělení, Moderated Session 1 „Dyslipidemia“)
2021 Korean Academy of Tuberculosis and Respiratory Diseases International Conference (KATRDIC 2021), Lotte Hotel World in Seoul, Korea, November 11 – 12, 2021 Yoon H-Y, Sikorová K, Petřek M, Strnad A, Kocourková L, Moon S-j, Song JW. Association of immune related genes with Sarcoidosis in the Korean Population.